Marie‐Thérèse Armentero

Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model

Fabio Blandini, Giovanna Levandis, Eleonora Bazzini et al. · European Journal of Neuroscience · 2007 · 183 citations

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease

Lidia Cova, Marie‐Thérèse Armentero, Eleonora Zennaro et al. · Brain Research · 2009 · 148 citations

Regenerative Medicine, Neuroregeneration, Medicine +11

Transplantation of Undifferentiated Human Mesenchymal Stem Cells Protects against 6-Hydroxydopamine Neurotoxicity in the Rat

Fabio Blandini, Lidia Cova, Marie‐Thérèse Armentero et al. · Cell Transplantation · 2010 · 140 citations · Full text

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease

Giovanna Levandis, Eleonora Bazzini, Marie‐Thérèse Armentero et al. · Neurobiology of Disease · 2007 · 102 citations · Full text

Unilateral Subthalamic Lesion, Mglur5 Antagonist, Medicine +7

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease

Marie‐Thérèse Armentero, Roberto Fancellu, Giuseppe Nappi et al. · Neurobiology of Disease · 2005 · 98 citations · Full text

Neurophysiology, Prolonged Blockade, Medicine +10